SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas Q3 earnings and outlook are driving attention: traders are weighing near-consensus results against weaker auto revenue and profitability, alongside heavy investment in AI and robotics. Bulls point to the earnings beat and future FSD, robotaxi, and Optimus potential, while bears question the valuation and spending; speculation about a SpaceX merger adds to the debate but remains unconfirmed.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas quarterly results drove attention, with revenue and advertising strength plus upbeat next-quarter guidance supporting a bullish reaction despite a reported earnings miss tied to a legal charge. Traders remain divided: bulls see AI and ad momentum, while skeptics cite rising AI spending, negative free cash flow, potential share dilution and legal risks.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Researchs strong quarterly results and higher outlook are being overshadowed by a sell-off, as traders question whether the next quarters slower growth pace and fab-capacity constraints justify high expectations. The community is split between calling the drop a sell-the-news overreaction and seeing it as profit-taking or concern that semiconductor demand may be near a peak.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBMs quarterly earnings beat expectations and its free-cash-flow outlook improved, but unchanged revenue guidance and modest growth fueled a mixed reaction. Bulls point to software momentum and cash generation, while skeptics cite flat consulting, infrastructure weakness, and the post-earnings fade.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is drawing attention after a sharp selloff alongside the broader semiconductor sector, as traders debate whether concerns about AI spending returns, financing risks and CEO Hock Tans gambling remarks have undermined the AI growth story. Bears point to the stocks weak performance and fear further declines, while bulls cite continued AI-chip demand and view the pullback as a buying opportunity.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is drawing attention as investors position around the FDAs pending decision on deramiocel for Duchenne muscular dystrophy, with the application now focused on upper-limb function and incorporating additional HOPE-3 extension data. Traders are split: bulls see a stronger case for the narrowed indication, while skeptics point to disputed trial analyses and the prior advisory committee vote as reasons another rejection remains possible; the uncertainty is accompanying a sharp share-price decline.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins rebound is driving a sharp move in Strategy shares, with traders debating whether the strength can continue or is vulnerable to a reversal and short squeeze. The discussion also weighs potential MSCI index exclusion against concerns about share dilution and the companys preferred-stock buyback program.

AEVEX Corp. operates as a holding company. It operates through Tactical Systems and Global Solutions segments. The Tactical Systems segment focuses on design, development, and production of autonomous systems including unmanned aerial systems and unmanned surface vessels. The Global Solutions segment offers services and mission support to defense and intelligence customers. The company was founded in 2017 and is headquartered in Solana Beach, CA.

AEVEX Corp. - Ordinary Shares - Class A

AEVEX Corp

The Navys reported halt to further purchases of AEVEXs GARC drone boats, citing hardware issues and cheaper alternatives, is driving a sharp selloff and questions about the BlackSea acquisition and management. Traders disagree on whether the lost procurement is a serious hit or an overreaction, noting that GARC is only one part of the business and other defense programs remain.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is drawing attention amid concerns about slowing sales in its core Celsius brand and uneven stock performance, with criticism of management and debate over whether Alani Nus growth can offset the weakness. Bulls point to insider buying and expanded retail placement as reasons for optimism, while a potential Pepsi buyout remains speculation.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

SLV is drawing attention after a sharp retreat in silver from its recent surge, with traders pointing to rising yields and a stronger dollar while debating why the metal has not acted as an inflation hedge. Sentiment is split between expectations of further declines and dip-buying on hopes the selloff is an oversold pullback; claims of deliberate market manipulation remain speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going on With Scilex Holding Stock Monday?

Scilex Holding Company signs a binding term sheet for a $100M strategic investment from iHolding Group LLP to fuel growth.read more...

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic...

Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health

Datavault AI Inc. (Datavault AI or the Company) (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset (RWA) tokenization technologies, today entered into a fully binding term sheet (the Binding Term Sheet) with Wellgistics Health, Inc. (Wellgistics...

PHOE Stock More Than Doubles On Strategic Pivot Into Pharma Industry With Scilex Deal

Equity

Scilex said that its indirect subsidiary ACEA Therapeutics, and wholly owned unit ACEA Pharma have entered into a definitive stock acquisition agreement with Hong Kong-based Phoenix Asia.


Scilex (NASDAQ:SCLX) Downgraded to "Strong Sell" Rating by Wall Street Zen

Wall Street Zen cut shares of Scilex from a "hold" rating to a "strong sell" rating in a report on Saturday...

Short Interest in Scilex Holding Company (NASDAQ:SCLX) Decreases By 15.4%

Scilex Holding Company (NASDAQ:SCLX - Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totaling...

Datavault AI (NASDAQ: DVLT) Secures $120M Term Sheet With Scilex for Quantum-Ready Edge Network Buildout

Datavault AI (NASDAQ: DVLT)&#160;announced it has executed a binding term sheet with&#160;Scilex&#160;Holding Company (NASDAQ: SCLX) for a $120 million upfront cash contribution tied to a revenue participation agreement supporting the deployment of its quantum-ready, zero trust edge network. Under the terms,&#160;Scilex&#160;will receive a tiered share of network revenues until defined caps are met, while&#160;Datavault&#160;AI retains [&#8230;]

Datavault AI (NASDAQ: DVLT) Executes $120M Term Sheet With Scilex for Quantum-Ready Edge Network Deployment

Datavault AI (NASDAQ: DVLT)&#160;announced it has executed a binding term sheet with Scilex Holding Company (NASDAQ: SCLX) for a $120 million cash contribution and revenue participation agreement to support deployment of its quantum-ready, zero trust edge network. Under the agreement, Scilex will receive a tiered share of network revenues up to defined caps, while the [&#8230;]

Datavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum Platform

Datavault AI Inc. (NASDAQ: DVLT) (Datavault AI or the Company), a provider of data monetization, credentialing, digital engagement, and real-world asset ('RWA') tokenization technologies, today...

Scilex (NASDAQ:SCLX) Announces Earnings Results

Scilex (NASDAQ:SCLX - Get Free Report) released its quarterly earnings results on Friday. The company reported ($4.60) earnings per share for the quarter, missing the consensus estimate of ($0.47) by...

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Bearish Sentiment

<ul class="summary-bullets"><li>Under the terms, ACEA Therapeutics will sell 100% of the issued and outstanding equity interests in ACEA Pharma to Phoenix.</li><li>In exchange, Phoenix will issue 100 million newly issued ordinary shares valued at $10.00 per share, for a total transaction value of $1 billion.</li><li>The deal is expected to close by the end of the second quarter of 2026.</li></ul> Shares of Phoenix Asia Holdings (PHOE) surged 169% on Tuesday after the company announced a $1 billion deal that will transform it into a pharmaceutical-industry holding company.Scilex (SCLX), which makes non-opioid pain management products, said on Tuesday that its indirect subsidiary ACEA Therapeutics, Inc., and wholly owned unit ACEA Pharma, Inc., have entered into a definitive stock acquisition agreement with Hong Kong-based Phoenix Asia.<h2 class="st-heading-2">Deal Terms</h2>Under the terms, ACEA Therapeutics will sell 100% of the issued and outstanding equity interests in ACEA Pharma to Phoenix. In exchange, Phoenix will issue 100 million newly issued ordinary shares valued at $10.00 per share, for a total transaction value of $1 billion.Upon closing, Phoenix will be renamed ACEA Pharma, Inc., and its common stock is expected to continue trading on The Nasdaq Stock Market. ACEA Therapeutics is projected to own approximately 82% of the post-deal entity.The boards of all three companies have unanimously approved the transaction. The deal is expected to close by the end of the second quarter of 2026, subject to customary closing conditions, including regulatory and stock-exchange approvals.Phoenix is currently primarily engaged in construction and substructure works in Hong Kong. Following the transaction, it will transform into a pharmaceutical-industry holding company.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around SCLX stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.Meanwhile, sentiment around PHOE jumped from ‘bullish’ to ‘extremely bullish’ levels, while retail chatter rose from ‘low’ to ‘extremely high’ levels.A Stocktwits user applauded the deal, terming it “only the beginning.”<stembedurl>https://www.stocktwits.com/BioCEOsSukk/message/652323584</stembedurl> &nbsp;&nbsp; While <a href="https://stocktwits.com/symbol/PHOE">PHOE stock</a> has rallied more than 1700% over the past 12 months, <a href="https://stocktwits.com/symbol/SCLX">SCLX shares</a> have nearly doubled.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/ebay-to-sit-down-this-week-to-ponder-on-gamestop-longshot-buyout-offer-report/cZQDIDlRe9M">eBay To Sit Down This Week To Ponder On GameStop’s Longshot Buyout Offer, Says Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Scilex said that its indirect subsidiary ACEA Therapeutics, and wholly owned unit ACEA Pharma have entered into a definitive stock acquisition agreement with Hong Kong-based Phoenix Asia.

Phoenix Asia Holdings Ltd.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.56
Prev Close	$2.53
Open	$2.51
Dividend Yield	0.00%
50-Day Moving Average	$4.84
Beta	0.99
Avg. Volume	30,082.72
PE Ratio	-0.05

52-Week High	$16.81
52-Week Low	$2.52
Market Capitalization	$17.8M
EPS (Annual)	-$36.48
Price to Book	-0.06
Revenue Per Employee	$889,794.12

Feed

News

Sentiment

Earnings

Fundamentals

Info

SCLX Fundamentals